Cancer Deaths Continue a Steep Decline


From 1991 to 2015, the cancer death rate dropped about 1.5 percent a year, resulting in a total decrease of 26 percent — 2,378,600 fewer deaths than would have occurred had the rate remained at its peak. Read more here.

The trials of Juno


IN THE pharma business, Juno Therapeutics, a small firm based in Seattle, is just a stripling. It is three years old, has not a single drug approval to its name but is nonetheless valued at $2.8 billion. That value is derived from the fact that it is on the forefront of the most promising area […]

Immune System and Spirit Kept Cancer at Bay for a Year

Immune System and Spirit Kept Cancer at Bay for a Year

I recently chronicled the story of Jason Greenstein and his battle against cancer. He was at the vanguard of a new kind of treatment that unleashes the immune system to fight the disease as it does infections caused by viruses and bacteria. But his reprieve lasted just over a year. Jason died last week, leaving […]

VP Biden gives new push on ‘Cancer Moonshot’ clinical trials

U.S. Vice President Joe Biden addresses the session "Cancer Moonshot: A Call to Action" during the annual meeting of the World Economic Forum (WEF) in Davos, Switzerland in this file photo dated January 19, 2016. REUTERS/Ruben Sprich

U.S. Vice President Joseph Biden on Friday announced new measures to help cancer patients navigate the clinical trials process as part of the administration’s “Cancer Moonshot” initiative to speed new treatments to market. In a statement released ahead of a planned speech at Rice University in Houston, Biden said clinical trials are essential for developing […]

Cancer-Drug Ads vs. Cancer-Drug Reality

cancer drug

By MATT JABLOW TOWSON, Md. — Two days into a long-dreamed-of family vacation to Italy in August 2013, my wife, Ronna, became nauseated, unusually tired and short of breath. One of the great non-complainers in American history, she insisted that it was no big deal and valiantly tried to join in on various outings in […]

Biden Threatens Funding Cuts


Vice President Biden speaks at the Cancer Moonshot Summit at Howard University in Washington on Wednesday. (Carolyn Kaster/AP) Biden threatens funding cuts for researchers who don’t report clinical-trial data An impatient Vice President Biden threatened Wednesday to cut funding to research facilities that fail to report clinical-trial results quickly enough and took a swipe at […]

Medicine’s Next Step


Trial Medication Treatment  By Barack Obama   JULY 07, 2016 HEALTH CARE is always personal. As science and technology have advanced, it’s become possible to make it personalized as well, giving us the tools to better understand, prevent, and treat everyone’s individual health needs. We wouldn’t buy a pair of glasses that doesn’t match our […]

Why Cancer Patients And Doctors Should Rethink The Value Of Phase 1 Trials

Elaine Schattner,  CONTRIBUTOR Of all the reports being presented at this year’s big cancer meeting, the one I think most important is not about a particular drug or malignancy. It’s about the design of clinical trials. For cancer patients trying an experimental drug, participating in a “matched” study–using biomarkers, like genetics, to link their condition […]

Nat Turner on Flatiron Health’s Emphasis on Community Oncologists


Flatiron Health focuses on helping community oncologists because they still care for the majority of patients with cancer and make it possible for patients to get care without traveling long distances, explained Nat Turner, co-founder and CEO of Flatiron Health. Watch video here.    

What Mormon Family Trees Tell Us About Cancer


By searching the church’s famed family trees, scientists have tracked down a cancer-causing mutation that came west with a pioneer couple—just in time to save the lives of their great-great-great-great grandchildren. Read more here.